TAYLOR WINSLOW: Open Payments
NPI 1164015970 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,531 in 129 payments from 19 companies in 2025. Trend: 2023 $1,111 · 2024 $2,732 · 2025 $2,531
Food & beverage: $2,531
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $630 |
| Janssen Biotech, Inc. | 11 | $263 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $187 |
| Regeneron Healthcare Solutions, Inc. | 7 | $177 |
| Ardelyx, Inc. | 16 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $162 |
| GENZYME CORPORATION | 6 | $147 |
| QOL Medical, LLC | 5 | $143 |
| PFIZER INC. | 10 | $142 |
| Lilly USA, LLC | 6 | $110 |
Products named: DUPIXENT, TREMFYA, XIFAXAN, SKYRIZI, IBSRELA, MAVYRET, Sucraid, LINZESS.
Industry payments across GA — which companies pay providers there.
